Biochemistry-Not Oncogenes-May Demystify and Defeat Cancer

Jay Kulsh1

  • 1Independent Scientist, Los Angeles, CA, USA. jkulsh@gmail.com.

Oncology and Therapy
|February 13, 2023
PubMed

Insights

Environmental factors, not just genes, are key to cancer development. Targeting the enzyme ribonucleotide reductase (RnR) offers a promising strategy for arresting tumor growth and treating cancer.

Area of Science:

  • Biochemistry
  • Oncology
  • Environmental Health

Background:

  • Decades of research have failed to identify specific causative genes for most cancers.
  • The Cancer Genome Atlas provided extensive data but limited insight into cancer's origins and progression.
  • Epidemiological studies increasingly highlight the environment's principal role in cancer etiology.

Purpose of the Study:

  • To investigate the role of environmental carcinogens in cancer development.
  • To explore the biochemical mechanisms underlying cancer initiation and progression.
  • To identify key enzymes involved in cancer, focusing on ribonucleotide reductase (RnR).

Main Methods:

  • Review of epidemiological and biochemical studies on cancer causation.
  • Analysis of the role of environmental factors, particularly carcinogenic chemicals.
  • Focus on the enzyme ribonucleotide reductase (RnR) and its function in DNA synthesis.

Main Results:

  • Environmental exposures, including chemicals in food, air, and water, are primary cancer culprits.
  • Ribonucleotide reductase (RnR), the rate-limiting enzyme in DNA synthesis, is closely linked to tumor growth.
  • RnR's active site is implicated in carcinogen-induced DNA damage, with documented roles in retinoblastoma and HPV-related cervical cancers.

Conclusions:

  • Environmental factors play a more significant role in cancer than previously emphasized.
  • Targeting the enzyme ribonucleotide reductase (RnR) presents a viable therapeutic strategy for cancer treatment.
  • Inhibiting malignant RnR activity can effectively arrest cancer progression.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.9K